The WuXi PharmaTech-led 6 Dimensions Capital has led the first tranche of neuromodulation technology developer Neuspera Medical's latest round.
US-based neuromodulation device developer Neuspera Medical has raised $26m from investors including 6 Dimensions Capital, which is backed by medical research firm WuXi PharmaTech, for the first close of its series B round.
Action Potential Venture Capital, Windham Venture Partners, Delta Capital and Purple Arch Ventures also participated in the tranche, which was led by 6 Dimensions, the investment firm formed by firm WuXi PharmaTech and venture capital firm Frontline BioVentures.
Founded in 2013, Neuspera Medical is developing technology that…
